CID 16131462

[3-[[5-(2-amino-6-oxo-1h-purin-9-yl)-3-[[5-(2-amino-6-oxo-1h-purin-9-yl)-3-[[5-(2-amino-6-oxo-1h-purin-9-yl)-3-[[3-[[5-(2-amino-6-oxo-1h-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl phenazin-1-yl hydrogen phosphate

Structural Information

Molecular Formula
C72H81N29O37P6
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC3=CC=CC4=NC5=CC=CC=C5N=C43)OP(=O)(O)OCC6C(CC(O6)N7C=NC8=C7N=C(NC8=O)N)OP(=O)(O)OCC9C(CC(O9)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)O
InChI
InChI=1S/C72H81N29O37P6/c1-28-15-96(72(108)95-63(28)103)46-10-34(40(128-46)17-122-139(109,110)133-33-8-4-7-31-51(33)86-30-6-3-2-5-29(30)85-31)134-141(113,114)124-19-42-36(12-48(130-42)99-25-82-54-60(99)88-69(75)92-65(54)105)137-143(117,118)126-21-44-38(14-50(132-44)101-27-84-56-62(101)90-71(77)94-67(56)107)138-144(119,120)125-20-43-37(13-49(131-43)100-26-83-55-61(100)89-70(76)93-66(55)106)136-142(115,116)123-18-41-35(11-47(129-41)97-23-80-52-57(73)78-22-79-58(52)97)135-140(111,112)121-16-39-32(102)9-45(127-39)98-24-81-53-59(98)87-68(74)91-64(53)104/h2-8,15,22-27,32,34-50,102H,9-14,16-21H2,1H3,(H,109,110)(H,111,112)(H,113,114)(H,115,116)(H,117,118)(H,119,120)(H2,73,78,79)(H,95,103,108)(H3,74,87,91,104)(H3,75,88,92,105)(H3,76,89,93,106)(H3,77,90,94,107)
InChIKey
INVOFVBOWYCOJE-UHFFFAOYSA-N
Compound name
[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl phenazin-1-yl hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

2129.3774 Da
Monoisotopic Mass

-10.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2130.3847 235.0
[M+Na]+ 2152.3666 244.8
[M-H]- 2128.3701 233.3
[M+NH4]+ 2147.4112 238.0
[M+K]+ 2168.3406 241.3
[M+H-H2O]+ 2112.3747 234.1
[M+HCOO]- 2174.3756 239.1
[M+CH3COO]- 2188.3913 240.9
[M+Na-2H]- 2150.3521 241.4
[M]+ 2129.3769 243.2
[M]- 2129.3779 243.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.